Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32334535
.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117 J+Headache+Pain
2020 ; 21
(1
): 38
Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Headache medication and the COVID-19 pandemic
#MMPMID32334535
MaassenVanDenBrink A
; de Vries T
; Danser AHJ
J Headache Pain
2020[Apr]; 21
(1
): 38
PMID32334535
show ga
The world is currently dominated by the Corona Virus Disease 2019 (COVID-19)
pandemic. Besides the obvious concerns about limitation of virus spread and
providing the best possible care to infected patients, a concomitant concern has
now arisen in view of a putative link between the use of certain drugs, such as
Renin-Angiotensin System (RAS) inhibitors and ibuprofen, and an increased risk
for COVID-19 infection. We here discuss this concern in relation to headache
treatment and conclude that, based on current evidence, there is no reason to
abandon treatment of headache patients with RAS inhibitors or ibuprofen.
|Angiotensin Receptor Antagonists/*adverse effects/therapeutic use
[MESH]
|Angiotensin-Converting Enzyme 2
[MESH]
|Angiotensin-Converting Enzyme Inhibitors/*adverse effects/therapeutic use
[MESH]
|Betacoronavirus
[MESH]
|COVID-19
[MESH]
|Coronavirus Infections/*pathology
[MESH]
|Headache/*drug therapy
[MESH]
|Humans
[MESH]
|Ibuprofen/*adverse effects/therapeutic use
[MESH]
free
free
free
